polynovo signed contract sale aod9604 lateral pharma Exclusives Archive Cancer R&D Partnerships, M&A and
Cancer R&D Partnerships, M&A and Venture Funding by Tech Q3 2025 Review DealForma AOD 9604 Simon's Compounding AOD 9604 (10mg vials) Peptide Partners PharmNovo enhances its Board ahead of Phase II development PharmNovo Home of PN6047, a new treatment for chronic pain PharmNovo
Pay in 4 interest-free payments of $5.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




